Postload plasma glucose concentration and 27-year prostate cancer mortality (United States)

[1]  C. Newschaffer,et al.  Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. , 2000, Journal of the National Cancer Institute.

[2]  Leif Øie,et al.  Is diabetes mellitus associated with prostate cancer incidence and survival , 1999 .

[3]  C. Mantzoros,et al.  Risk factors for prostate cancer: a case‐control study in Greece , 1999, International journal of cancer.

[4]  C. Mantzoros,et al.  Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. , 1998, Journal of the National Cancer Institute.

[5]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[6]  Meir J. Stampfer,et al.  Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .

[7]  A. Dyer,et al.  One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. , 1997, Journal of clinical epidemiology.

[8]  A. Dyer,et al.  Diabetes, Asymptomatic Hyperglycemia, and 22-Year Mortality in Black and White Men: The Chicago Heart Association Detection Project in Industry Study , 1997, Diabetes Care.

[9]  M. Stampfer,et al.  Prospective study of sex hormone levels and risk of prostate cancer. , 1996, Journal of the National Cancer Institute.

[10]  S. Coughlin,et al.  Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[11]  K. Steenland,et al.  Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  A. Dyer,et al.  Heart rate and prostate cancer mortality: results of a prospective analysis. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  C. la Vecchia,et al.  A case-control study of diabetes mellitus and cancer risk. , 1994, British Journal of Cancer.

[14]  L. Phillips,et al.  Differential regulation of IGF-1 and IGF-binding protein-1 by dietary composition in humans. , 1993, The American journal of the medical sciences.

[15]  M. Marmot,et al.  Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. , 1992, American journal of epidemiology.

[16]  J. Stamler,et al.  Relationship of Postload Plasma Glucose to Mortality With 19-Yr Follow-Up. Comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas Company Study , 1992, Diabetes Care.

[17]  D. Silverman,et al.  Cancer risk in patients with diabetes mellitus , 1991, Cancer Causes & Control.

[18]  D. Peehl,et al.  Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. , 1991, The Journal of clinical endocrinology and metabolism.

[19]  P. Bennett,et al.  A two-step model for development of non-insulin-dependent diabetes. , 1991, The American journal of medicine.

[20]  E. Barrett-Connor,et al.  Endogenous sex hormone levels in older adult men with diabetes mellitus. , 1990, American journal of epidemiology.

[21]  E. Barrett-Connor,et al.  Heart disease risk factors, diabetes, and prostatic cancer in an adult community. , 1989, American journal of epidemiology.

[22]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[23]  M. Seppälä,et al.  Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. , 1988, The Journal of clinical endocrinology and metabolism.

[24]  A. Maccuish,et al.  Oestradiol levels in diabetic men with and without a previous myocardial infarction. , 1987, The Quarterly journal of medicine.

[25]  A. Dyer,et al.  Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. , 1986, American journal of epidemiology.

[26]  J. Stamler,et al.  Prevalence of diabetes/hyperglycemia and associated cardiovascular risk factors in blacks and whites: Chicago Heart Association Detection Project in Industry. , 1984, American heart journal.

[27]  A. Dyer,et al.  Multivariate analysis of the relationship of six variables to blood pressure: findings from Chicago community surveys, 1965--1971. , 1975, Journal of chronic diseases.

[28]  B. Henderson,et al.  Evaluation of cancer risk factors in a retirement community. , 1974, Cancer research.

[29]  K. Mabuchi,et al.  Epidemiology of cancer of the prostate , 1971, Cancer.

[30]  W. Hoffman.  A RAPID PHOTOELECTRIC METHOD FOR THE DETERMINATION OF GLUCOSE IN BLOOD AND URINE , 1937 .

[31]  E. Rimm,et al.  Diabetes mellitus and risk of prostate cancer (United States) , 2004, Cancer Causes & Control.

[32]  D. Roith.  Insulin-like Growth Factors , 2002 .

[33]  C. Mantzoros,et al.  Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. , 1997, British Journal of Cancer.

[34]  L. Kuller,et al.  Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[35]  B. Hulka,et al.  Medical, life‐style, and occupational risk factors for prostate cancer , 1987, The Prostate.

[36]  B. A. O'Mara,et al.  Diabetes mellitus and cancer risk: a multisite case-control study. , 1985, Journal of chronic diseases.

[37]  J. Stamler,et al.  Methodological problems in characterizing an individual's plasma glucose level. , 1982, Journal of chronic diseases.

[38]  L. Melton,et al.  Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. , 1982, Journal of chronic diseases.